CIK 0001484612
- Accelerated filer
- Smaller reporting company
Outset Medical, Inc.
Sign in to watch- Ticker
- OM
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 200514392
- Phone
- +1 669-231-8200
- Business address
- 3052 ORCHARD DRIVE, SAN JOSE, CA, 95134
- Former names
- Home Dialysis Plus, Ltd.
- Open-market buys, last 90 days
- $870,260
- in 1 filing
- Open-market sales, last 90 days
- $28,997
- in 2 filings
Net +$841,264. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-03 | Brottem John L. General Counsel | Sale 10b5-1 | −1,414 | $20.00 | $28K | 61,597 |
| 2023-05-03 | Brottem John L. General Counsel | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −1,414 | 19,804 | ||
| 2023-05-03 | Trigg Leslie Chair and CEO | Option exercise 10b5-1 | +20,000 | $4.11 | $82K | 432,451 |
| 2023-05-03 | Trigg Leslie Chair and CEO | Sale 10b5-1 | −20,000 | $20.01 | $400K | 412,451 |
| 2023-05-03 | Trigg Leslie Chair and CEO | Option exercise 10b5-1 | +9,492 | $4.11 | $39K | 421,943 |
| 2023-05-03 | Trigg Leslie Chair and CEO | Sale 10b5-1 | −9,492 | $20.00 | $190K | 412,451 |
| 2023-05-03 | Trigg Leslie Chair and CEO | Option exercise 10b5-1 | +10,508 | $3.88 | $41K | 422,959 |
| 2023-05-03 | Trigg Leslie Chair and CEO | Sale 10b5-1 | −10,508 | $20.00 | $210K | 412,451 |
| 2023-05-03 | Trigg Leslie Chair and CEO | Option exercise · Performance Options (right to buy) 10b5-1 | −10,508 | 0 | ||
| 2023-05-03 | Trigg Leslie Chair and CEO | Option exercise · Performance Options (right to buy) 10b5-1 | −20,000 | 94,910 | ||
| 2023-05-03 | Trigg Leslie Chair and CEO | Option exercise · Performance Options (right to buy) 10b5-1 | −9,492 | 85,418 | ||
| 2023-03-20 | Brottem John L. General Counsel | Option exercise | +1,415 | $9.48 | $13K | 65,727 |
| 2023-03-20 | Brottem John L. General Counsel | Sale | −1,415 | $20.82 | $29K | 64,312 |
| 2023-03-20 | Brottem John L. General Counsel | Sale | −2,715 | $20.82 | $57K | 61,597 |
| 2023-03-20 | Brottem John L. General Counsel | Option exercise · Non-Qualified Stock Option (right to buy) | −1,415 | 21,218 | ||
| 2023-03-01 | Trigg Leslie Chair and CEO | Option exercise | +30,000 | $3.88 | $116K | 442,451 |
| 2023-03-01 | Trigg Leslie Chair and CEO | Sale | −30,000 | $22.48 | $674K | 412,451 |
| 2023-03-01 | Trigg Leslie Chair and CEO | Option exercise · Performance Options (right to buy) | −30,000 | 10,508 | ||
| 2023-03-01 | Vazquez Martin Chief Operating Officer | Option exercise | +5,000 | $3.88 | $19K | 108,112 |
| 2023-03-01 | Vazquez Martin Chief Operating Officer | Sale | −5,000 | $22.33 | $112K | 103,112 |
Page 13 of 18 · 343 trades